MSD Pharmaceuticals RX
FDA Approved Drugs

MSD Pharmaceuticals RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 13
  • Latest Approval Date Jul 15, 2026
  • Data Source FDA
  • First Approval Date Mar 26, 2003
All
14
View
Discontinued
1
View
RX
13
View
Company Overview

Company

MSD Pharmaceuticals RX

Country

India

Website

Visit Website

Email

contactmsdindia@merck.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

MSD Pharmaceuticals RX

Platina, 8th Floor, C.59, G Block, Bandra Kurla Complex, Bandra (East) , Mumbai - 400098,

India

www.msdindia.in/ contactmsdindia@merck.com View on Map
FDA Approved Drug Records ( 13 records )
2003
26 Mar
RX Application: 21549

Drug Name

EMEND

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2003-03-26

21549 / 1

Active Ingredient

APREPITANT

Application Number

21549

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2003-03-26

Regulatory Status

RX

2003
26 Mar
RX Application: 21549

Drug Name

EMEND

Product Number

2

Dosage Form

-

Strength

125MG

Approval Date

2003-03-26

21549 / 2

Active Ingredient

APREPITANT

Application Number

21549

Product Number

2

Dosage Form

-

Strength

125MG

Approval Date

2003-03-26

Regulatory Status

RX

2026
20 Apr
RX Application: 216964

Drug Name

IDVYNSO

Product Number

1

Dosage Form

-

Strength

100MG;0.25MG

Approval Date

2026-04-20

216964 / 1

Active Ingredient

DORAVIRINE; ISLATRAVIR

Application Number

216964

Product Number

1

Dosage Form

-

Strength

100MG;0.25MG

Approval Date

2026-04-20

Regulatory Status

RX

2006
16 Oct
RX Application: 21995

Drug Name

JANUVIA

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2006-10-16

21995 / 1

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

21995

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2006-10-16

Regulatory Status

RX

2006
16 Oct
RX Application: 21995

Drug Name

JANUVIA

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2006-10-16

21995 / 2

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

21995

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2006-10-16

Regulatory Status

RX

2006
16 Oct
RX Application: 21995

Drug Name

JANUVIA

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2006-10-16

21995 / 3

Active Ingredient

SITAGLIPTIN PHOSPHATE

Application Number

21995

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2006-10-16

Regulatory Status

RX

2026
15 Jul
RX Application: 220848

Drug Name

LIPFENDRA

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2026-07-15

220848 / 1

Active Ingredient

ENLICITIDE DECANOATE

Application Number

220848

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2026-07-15

Regulatory Status

RX

2024
26 Jun
RX Application: 217389

Drug Name

OHTUVAYRE

Product Number

1

Dosage Form

-

Strength

3MG/2.5ML

Approval Date

2024-06-26

217389 / 1

Active Ingredient

ENSIFENTRINE

Application Number

217389

Product Number

1

Dosage Form

-

Strength

3MG/2.5ML

Approval Date

2024-06-26

Regulatory Status

RX

2024
30 Aug
RX Application: 219104

Drug Name

PREVYMIS

Product Number

1

Dosage Form

-

Strength

20MG/PACKET

Approval Date

2024-08-30

219104 / 1

Active Ingredient

LETERMOVIR

Application Number

219104

Product Number

1

Dosage Form

-

Strength

20MG/PACKET

Approval Date

2024-08-30

Regulatory Status

RX

2024
30 Aug
RX Application: 219104

Drug Name

PREVYMIS

Product Number

2

Dosage Form

-

Strength

120MG/PACKET

Approval Date

2024-08-30

219104 / 2

Active Ingredient

LETERMOVIR

Application Number

219104

Product Number

2

Dosage Form

-

Strength

120MG/PACKET

Approval Date

2024-08-30

Regulatory Status

RX

2021
19 Jan
RX Application: 214377

Drug Name

VERQUVO

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2021-01-19

214377 / 1

Active Ingredient

VERICIGUAT

Application Number

214377

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2021-01-19

Regulatory Status

RX

2021
19 Jan
RX Application: 214377

Drug Name

VERQUVO

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2021-01-19

214377 / 2

Active Ingredient

VERICIGUAT

Application Number

214377

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2021-01-19

Regulatory Status

RX

2021
19 Jan
RX Application: 214377

Drug Name

VERQUVO

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2021-01-19

214377 / 3

Active Ingredient

VERICIGUAT

Application Number

214377

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2021-01-19

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    14 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
13 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

EMEND

Application Number

21549

Product Number

1

Active Ingredient

APREPITANT

Dosage Form

-

Strength

80MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit